VERGANI, ELISABETTA
VERGANI, ELISABETTA
Universita' degli Studi di MILANO
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
2022 E. Vergani, G.L. Beretta, M. Aloisi, M. Costantino, C. Corno, S. Frigerio, S. Tinelli, M. Dugo, F.M. Accattatis, A. Granata, L. Arnaboldi, M. Rodolfo, P. Perego, L. Gatti
Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction
2020 J. Gliozzo, P. Perlasca, M. Mesiti, E. Casiraghi, V. Vallacchi, E. Vergani, M. Frasca, G. Grossi, A. Petrini, M. Re, A. Paccanaro, G. Valentini
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30+ T lymphocytes with progression
2014 V. Vallacchi, E. Vergani, C. Camisaschi, P. Deho, A.D. Cabras, M. Sensi, L. De Cecco, N. Bassani, F. Ambrogi, A. Carbone, F. Crippa, B. Vergani, P. Frati, F. Arienti, R. Patuzzo, A. Villa, E. Biganzoli, S. Canevari, M. Santinami, C. Castelli, L. Rivoltini, M. Rodolfo
BRAF AND MAPK PATHWAY MOLECULES FOR TARGETED THERAPY OF MALIGNANT MELANOMA
2012 E. Vergani